🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to assess the therapeutic efficacy and safety of venetoclax...
Status
Unknown
Location
Department of Hematology,920th Hospital of Joint Logistic Support Force of People's Liberation
Start Date
2023-02-01
Trial ID
NCT05807347
Treatments Being Tested
This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Status
Recruiting
Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Start Date
2024-01-01
Trial ID
NCT06429098
Treatments Being Tested
SLS009 (formerly GFH009) is a potent and highly selective CDK9 inhibitor. I...
Status
Recruiting
Location
O'Neal Comprehensive Cancer Center, University of Alabama
Start Date
2021-05-10
Trial ID
NCT04588922
Treatments Being Tested
Pegylated arginine deiminase (ADI-PEG 20) will be combined with venetoclax ...
Status
Active Not Recruiting
Location
Sylvester Comprehensive Cancer Center
Start Date
2022-04-05
Trial ID
NCT05001828
Treatments Being Tested
To assess the safety and efficacy of galinpepimut-S (GPS) compared with inv...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Start Date
2021-02-08
Trial ID
NCT04229979
Treatments Being Tested
This study is aimed to evaluate the efficacy, safety, immunogenicity and ph...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2022-07-08
Trial ID
NCT05448599
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of venetoc...
Status
Recruiting
Location
The First Affliated Hospital of Soochow University
Start Date
2022-04-01
Trial ID
NCT05376111
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, drug level...
Status
Recruiting
Location
Yale-New Haven Hospital
Start Date
2024-05-29
Trial ID
NCT06419634
Treatments Being Tested
This phase I trial studies the side effects and best dose of ruxolitinib wh...
Status
Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2019-08-16
Trial ID
NCT03874052
During the last fifteen years, the landscape of AML diagnosis and therapeut...
Status
Recruiting
Location
Chu Amiens
Start Date
2022-04-14
Trial ID
NCT04777916